Cover Image

The emergence of NASH issues after cure of hepatitis C

Saved in:

Bibliographic Details
Main Author:	Lawrence Serfaty (Author)
Format:	Book
Published:	Elsevier, 2018-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Exercise of high intensity ameliorates hepatic inflammation and the progression of NASH
by: Gavin Fredrickson, et al.
Published: (2021)

A CURE FOR RECENTLY ACQUIRED HEPATITIS C
by: Radka Komitova, et al.
Published: (2022)

Liver ultrasound scanning in the detection of hepatic steatosis and fibrosis in NASH patients
by: Mona Hegazy, et al.
Published: (2012)

Implementation of hepatitis C cure in Australia: one year on
by: Jacqueline A. Richmond, et al.
Published: (2018)

NAShI AVTORY
by: -
Published: (2016)

NAShI AVTORY
by: -
Published: (2015)

NAShI AVTORY
by: -
Published: (2016)

NAShI AVTORY
by: -
Published: (2015)

NAShI AVTORY
by: -
Published: (2015)

"Sell an Ox" - The Price of Cure for Hepatitis C in Two Countries
by: Ora Paltiel, et al.
Published: (2020)

NASH E OS PASTEIS
by: Alexandre Godinho Bertoncello, et al.
Published: (2016)

NASH E OS PASTEIS
by: Alexandre Godinho Bertoncello, et al.
Published: (2016)

NASH and Systemic Complications From Basic to Clinical Research
Published: (2022)

Vitamin C Deficiency May Delay Diet-Induced NASH Regression in the Guinea Pig
by: Josephine Skat-Rørdam, et al.
Published: (2021)

Unraveling Hepatic Metabolomic Profiles and Morphological Outcomes in a Hybrid Model of NASH in Different Mouse Strains
by: Gabriel P. Bacil, et al.
Published: (2023)

Evolving Role for Pharmacotherapy in NAFLD/NASH
by: Suzanna L. Attia, et al.
Published: (2021)

Imaging biomarkers of NAFLD, NASH, and fibrosis
by: Veeral Ajmera, et al.
Published: (2021)

Bofutsushosan (Fangfengtongshengsan) improves early stages of NASH via the gut-liver axis in diabetes-induced NASH model mice
by: Mitsue Nishiyama, et al.
Published: (2024)

Progression and Regression of Hepatic Lesions in a Mouse Model of NASH Induced by Dietary Intervention and Its Implications in Pharmacotherapy
by: Zhi-Ming Ding, et al.
Published: (2018)

The road to elimination of hepatitis C: analysis of cures versus new infections in 91 countries
by: Andrew M. Hill, et al.
Published: (2017)

P71 High hepatitis C cure rate in a general practice cohort
by: D. Baker, et al.
Published: (2017)

Sofosbuvir/velpatasvir regimen promises an effective pan-genotypic hepatitis C virus cure
by: Mir F, et al.
Published: (2017)

Eight-week treatment with sofosbuvir/velpatasvir may be effective in curing hepatitis C in children
by: Maria Pokorska-Śpiewak, et al.
Published: (2024)

Hepatitis C From Infection to Cure
Published: (2018)

Genistein Modulated Lipid Metabolism, Hepatic PPARγ, and Adiponectin Expression in Bilateral Ovariectomized Rats with Nonalcoholic Steatohepatitis (NASH)
by: Sudaporn Pummoung, et al.
Published: (2020)

Corrigendum: Progression and Regression of Hepatic Lesions in a Mouse Model of NASH Induced by Dietary Intervention and Its Implications in Pharmacotherapy
by: Zhi-Ming Ding, et al.
Published: (2020)

Suppression of insulin-induced gene 1 (INSIG1) function promotes hepatic lipid remodelling and restrains NASH progression
by: Vian Azzu, et al.
Published: (2021)

The Choise of Valentines; Or the Merie Ballad of Nash His Dildo
by: Nash, Thomas, 1567-1601; Farmer, John Stephen, 1854-1916 [Editor]

Nuclear hormone and peptide hormone therapeutics for NAFLD and NASH
by: Brian Finan, et al.
Published: (2021)

FGF19 and FGF21: In NASH we trust
by: Saswata Talukdar, et al.
Published: (2021)

Novel oral SPT inhibitor CH5169356 inhibits hepatic stellate cell activation and ameliorates hepatic fibrosis in mouse models of non‐alcoholic steatohepatitis (NASH)
by: Natsuko Hada, et al.
Published: (2023)

Cholesterol Induces Oxidative Stress, Mitochondrial Damage and Death in Hepatic Stellate Cells to Mitigate Liver Fibrosis in Mice Model of NASH
by: Einat Rauchbach, et al.
Published: (2022)

Dietary Intervention Accelerates NASH Resolution Depending on Inflammatory Status with Minor Additive Effects on Hepatic Injury by Vitamin E Supplementation
by: Julie Hviid Klaebel, et al.
Published: (2020)

Pilot Sub-Study of the Effect of Hepatitis C Cure by Glecaprevir/Pibrentasvir on the Gut Microbiome of Patients with Chronic Hepatitis C Genotypes 1 to 6 in the Mythen Study
by: Bahtiyar Yilmaz, et al.
Published: (2021)

P39 Does the cure for hepatitis C start at moment of diagnosis? An analysis of Canadian women's experiences
by: S. Mitchell, et al.
Published: (2017)

Higher Hepatitis C Cure Rates in a Patient-Centered Medical Home Compared to Specialist Care
by: Jonathan Hughes, et al.
Published: (2023)

Experimental and Investigational Targeted Therapies for the Management of Fibrosis in NASH: An Update
by: Huisman TM, et al.
Published: (2021)

Interdisciplinary advances reshape the delivery tools for effective NASH treatment
by: Linshan Chen, et al.
Published: (2023)

Influence of Sleeve Gastrectomy on NASH and Type 2 Diabetes Mellitus
by: W. K. Karcz, et al.
Published: (2011)

Hepatitis type B is preventable and can be cured
by: Nikpoor
Published: (2001)